secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0001493152-24-009224
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.03, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX draws $500K, sets warrant dividend and reverse split for Serina merger
---------------------------------------------------------------------------

- Drew $500,000 under secured convertible note with Juvenescence; repayment due May 9, 2024.
- Declared warrant dividend: three Post-Merger Warrants per five shares held, exercise price $13.20, expiring July 31, 2025.
- Reverse stock split expected March 14, 2024; trading on split-adjusted basis March 15, 2024.
- Special meeting on March 14, 2024 to vote on warrant dividend and reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224009224/0001493152-24-009224-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224009224/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-009224

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer